GENFLOW BIOSCIENCES PLC
GENF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BP2C3V08
- LEI:
- 213800HVOFXRXVEGDN62
- Country:
- United Kingdom
- Address:
- 6 HEDDON STREET, W1B 4BT LONDON
- Website:
- https://genflowbio.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Genflow Biosciences PLC is a UK-based biotech firm dedicated to discovering and advancing new therapeutic approaches to halt or slow the ageing process for longer, healthier lives.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-24 08:00 |
Regulatory News Service
Clinical Readiness Acceleration
|
English | 17.7 KB | |
| 2025-07-17 08:00 |
Regulatory News Service
Genflow Confirms Progression of Grant
|
English | 18.0 KB | |
| 2025-06-12 11:16 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 30.5 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
Genflow Signs Master Services Agreement
|
English | 13.4 KB | |
| 2025-05-15 08:00 |
Regulatory News Service
Key SIRT6 Patent Application
|
English | 12.3 KB | |
| 2025-05-12 11:50 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 68.7 KB | |
| 2025-05-07 19:07 |
Annual Report (ESEF)
Annual financial statements 2024
|
English | 493.4 KB | |
| 2025-05-07 19:07 |
Annual Audited Financial Statements
Annual financial statements 2024
|
English | 1.5 MB | |
| 2025-03-28 08:10 |
Declaration of Voting Results & Voting Rights Announcements
Holding in Company
|
English | 23.0 KB | |
| 2025-03-28 08:00 |
Transaction in Own Shares
Director Dealings
|
English | 25.2 KB | |
| 2025-03-26 08:00 |
Inside Information Statement
Institutional Investment
|
English | 19.6 KB | |
| 2025-02-20 08:00 |
Regulatory News Service
Advancements in SIRT6 Variant Patent Application
|
English | 19.4 KB | |
| 2025-01-13 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 22.3 KB | |
| 2025-01-13 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 24.4 KB | |
| 2025-01-06 08:00 |
Business and Financial Review
2024 Highlights
|
English | 18.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |